These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two support the notion of focusing on ACKR3 as a unique approach to modulate the opioid process, which could open new therapeutic avenues for opioid-related Conditions. Improve healthier immune purpose: Conolidine https://stratfordq603ggg6.azuria-wiki.com/user